Axsome Therapeutics shares owned by Bellevue Group
Quarter-by-quarter ownership of Axsome Therapeutics (AXSM) shares owned by Bellevue Group
from 13F filings
Historical chart of Bellevue Group investment in Axsome Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Axsome Therapeutics held by Bellevue Group consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Axsome Therapeutics by Bellevue Group
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $51M | 635k | 79.59 |
2023-09-30 | $44M | 632k | 69.89 |
2023-06-30 | $41M | 574k | 71.86 |
2023-03-31 | $27M | 441k | 61.68 |
2022-12-31 | $34M | 437k | 77.13 |
2022-09-30 | $22M | 497k | 44.62 |
2022-06-30 | $31M | 817k | 38.30 |
2022-03-31 | $30M | 720k | 41.39 |
2021-12-31 | $25M | 652k | 37.78 |
2021-09-30 | $25M | 753k | 32.96 |
2021-06-30 | $24M | 352k | 67.46 |